Physician

Ryan Alan Shields, MD

According to 2025 Medicare claims, Ryan Shields, MD (NPI: 1255726618) practices ophthalmology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 33472-2981.

Shields' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 990 traditional Medicare patients, billed 37,521 HCPCS/CPT codes, and received $2,841,707 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 550 prescription claims across 244 beneficiaries totaling $47,510 in drug costs, led by Tobramycin-Dexamethasone (Tobramycin/Dexamethasone). Open Payments data shows 24 records totaling $3,143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,667 to $2,841,707. Similarly, Part D prescription costs have moved sharply higher in recent years, from $9,017 to $47,510. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2019 Medicare payment: $6,667 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $13,042 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $450,220 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,021,501 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,764,045 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,841,707 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20194068$6,667
202095140$13,042
20214592,121$450,220
202290010,989$2,021,501
20231,01630,899$2,764,045
202499037,521$2,841,707

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$63K$127K2019 Drug cost: $9,017 (USD; Tot_Drug_Cst)2020 Drug cost: $25,195 (USD; Tot_Drug_Cst)2021 Drug cost: $25,879 (USD; Tot_Drug_Cst)2022 Drug cost: $37,781 (USD; Tot_Drug_Cst)2023 Drug cost: $126,807 (USD; Tot_Drug_Cst)2024 Drug cost: $47,510 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201977171$9,017
2020214594$25,195
2021194524$25,879
2022197492$37,781
2023249630$126,807
2024244550$47,510

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2631,948$650
67028Injection of drug into eye3861,482$104
92014Established patient complete exam of visual system558781$97
92012Established patient problem focused exam of visual system332519$71
92134Imaging of retina8152,125$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tobramycin-DexamethasoneTobramycin/Dexamethasone1324,130$8,925
Prednisolone AcetatePrednisolone Acetate1166,310$5,963
Bromfenac SodiumBromfenac Sodium25927$4,822
DifluprednateDifluprednate521,168$4,346
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat453,890$736

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$3,143Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ryan Alan Shields, MD?

Tedicare shows public-source Medicare data for Ryan Alan Shields, MD (NPI 1255726618), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Alan Shields, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Alan Shields, MD?

Ryan Alan Shields, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Ryan Alan Shields, MD have Open Payments data?

Ryan Alan Shields, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.